Latest From Biotech Now

Biotech in the age of new media

In the age of new media, sharing information about a prescription drug is even more perilous than ever. Despite promises of guidelines in 2009, the FDA still has yet to issue clear guidance to pharmaceutical companies about how to remain in compliance with regulations while using the appealing and affordable medium of new media to disseminate information. In their panel, “Talking About Your Product in the New Age: Social Media and the Internet,” moderator John Read More >

Corporate  |  Leave a comment  |  Email This Post

Tony Blair Talks Biotech

From Snapshot At Monday’s keynote luncheon, former British Prime Minister Tony Blair was quizzed about his motives for seeking office and his feelings about the criticism he received for allying with former President Bush. Interesting, but just as I was beginning to wonder if Blair would comment on the biotech industry, he did. Succinctly and with British understatement.  When BIO president Jim Greenwood asked how Blair saw the role of government in advancing biotech, he Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

2011 BIO International Convention: Talent is Talent

From Trade Secrets Even if the total numbers of attendees at BIO is down from its peak, it’s still an incredibly large gathering of diverse people across the biotech spectrum. The exhibit hall is a good reflection of that. I can remember when the hall was just a collection of simple individual company stands – a few employees in a booth, a poster hanging behind them. But as the industry grew, the exhibitors changed; the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

Perspectives from Brazil, India, Argentina, and South Africa

From PharmaTech Talk At this week’s Partnering for Global  Health Forum, sponsored by BIO and BioVentures for Global Health, in Washington, DC, a unique panel of government leaders from emerging markets discussed what it takes to do business in their countries. Among the panelists were: Argentina’s Lino Barañao, Minister of Science, Technology and Innovative Production; India’s Maharaj K. Bhan, Secretary, Department of Biotechnology; South Africa’s Bongi Gumede, Senior General Manager, Technology Innovation and Marketing, Technology Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,

Competition gets fierce for innovative science

From FierceBiotech At the height of recession, biotechs were hurting for cash. Big Pharma and its deep pockets were there to cherry-pick the best science at an affordable price from small companies that had little choice but to make deals. But the balance of power has shifted in the past year. Pharma is now face-to-face with the patent cliff, and hardly a week goes by without mention of the industry’s unproductive, yet very costly, R&D Read More >

Events  |  Leave a comment  |  Email This Post
Tags: ,